Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to ...

Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by ...

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

2025 hasn't been kind to Kenvue ( KVUE +15.03%) stock lately. Shares of the one-time Johnson & Johnson unit got hit hard after President Donald Trump said it was "not good" for women to take Tylenol ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.